TILRAY SHORT TERM OPPORTUNITY
Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, and Latin America.
Second asset of the cannabis sector analyzed. Bullish divergence on the daily timeframe flanked by a double top that heralds a probable bullish bottom. Target price $ 17 - $ 21. Take into account the riskiness of the sector when managing this asset. Plenty of room for maneuver for various investment strategies.
Second asset of the cannabis sector analyzed. Bullish divergence on the daily timeframe flanked by a double top that heralds a probable bullish bottom. Target price $ 17 - $ 21. Take into account the riskiness of the sector when managing this asset. Plenty of room for maneuver for various investment strategies.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.